印度氨基氨酸胺路径是心血管疾病的潜在生物标志物
Khaled Naja1, Najeha Anwardeen1, Mashael Al-Shafai1,2
1Biomedical Research Center, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Biomolecules
|March 28, 2025
概括
新型肠道微生物群代谢物与心血管疾病 (CVD) 有关. 甲基胺路径的改变可能会增加心血管疾病的风险,为早期检测和肠心轴干预提供新的途径.
科学领域:
- 代谢学 代谢学 代谢学
- 微生物组研究的研究.
- 心血管疾病的研究研究.
背景情况:
- 心血管疾病 (CVD) 是一个主要的全球健康问题.
- 代谢学为早期检测和风险评估提供了识别心血管疾病生物标志物的潜力.
- 肠道微生物群的代谢物因其在慢性疾病中的作用而越来越被认可.
研究的目的:
- 确定与心血管疾病相关的新型代谢生物标志物.
- 研究肠道微生物群代谢与心血管健康之间的联系.
- 探索肠心轴内的潜在治疗点.
主要方法:
- 横截面研究设计. 截面研究设计.
- 非向的代谢学分析.
- 来自卡塔尔生物银行的112名心血管疾病患者和112名健康对照人群之间的代谢资料比较.
- 使用OPLS-DA和线性模型进行统计分析.
主要成果:
- 研究人员发现,印乐乙谷氨胺通路与心血管疾病之间存在显著的关联.
- 在心血管疾病患者中观察到肠道微生物群代谢的变化,包括增加的乙酸和乙酸.
- 随着心血管疾病的出现,人们注意到心脏保护性英多 propionate 的潜在下降.
结论:
- 甲基胺路径是心血管疾病的潜在新生物标志物.
- 肠道微生物群失生可能会导致心血管疾病的发展.
- 这些发现表明,针对肠心轴的CVD风险评估和治疗的新策略.
更多相关视频
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
06:33Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence
Published on: July 5, 2021
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...